PLK2 has been reported to be tumor suppressive in B-cell neoplasia, laryngeal carcinoma, cervical cancer cell lines, and patient samples by promoting apoptosis and inhibiting cell proliferation (34, 63, 64). Here, PLK2 is linked to laryngeal carcinoma.